Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000177902 | SCV000229861 | uncertain significance | not provided | 2015-05-28 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000177902 | SCV001018513 | benign | not provided | 2024-01-13 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000177902 | SCV001748419 | benign | not provided | 2022-07-01 | criteria provided, single submitter | clinical testing | CHD8: BS1, BS2 |
Gene |
RCV000177902 | SCV001942265 | benign | not provided | 2020-01-24 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002390434 | SCV002670596 | likely benign | Inborn genetic diseases | 2017-06-22 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |